NEW YORK (GenomeWeb News) – AltheaDx today announced that it has been named an Affymetrix authorized service provider.
The San Diego-based molecular testing services provider said that the deal enables it to offer biomarker discovery and development services based on Affy’s GeneChip microarray platform. It said it would use the genotyping and gene expression platform to identify new biomarkers and analyze gene pathways that are critical to the development and progression of cancer.
Terms of the alliance were not disclosed.